
Yilifang Biotech.
Shenzhen Yilifang Biotechnology Co.,εδ Ltd. was
establishe §d in 2013. It is a nati∑ ∏onal high-tech enterprise integrating t∞ he
development, producλ≥₹tion and sales of prec✔™₽ision medical in vitro diagnostic
←α✔÷
reagents. The companychr←∞↕(34)s research and development tea★εm consist of scientific
researchers from top ★™'σinternational institutions and domestic translati↔♠♣<on
medical elites, including high-quality talent s of national leading talents, Class
B peacocαδ≥k talents, and reserve talents. Targetinδ₩™βg existing "pain
points" in the market, Yilifang↑ ✘ links with domestic and foreign
cutting-↓δedge technologies and≥•☆ committed to creating good products that c× ≤₩an
truly address the demands ∑←¶≠form the market.
Product architecture
From the major diseases th↔α at the society needs
to solve urgently,α Yilifang has built prod≤☆ucts in four major sectors. It has
s✔®uccessfully developed more→★ than 20 Class III in vitro diagnostic prod ←ucts, and
its products have α"↑gradually entered the national registrati§™on stage.
Yilifang was established in the✘≈ new era of
precision medicine. Since its ♣inception, Yilifang has been pragmatic and
prudeε↕αnt in its work style. It has vigor£γ ±ously coordinated dev®♠<elopment in talent
cultivation, '₽research and development innovation, safety compπ™δliance, and
quality system constr♠→uction, etc. It has also made initial achieve∑&ments. In
terms of talent training, a✘<£§ high-quality elite team has been created. ₩★<$Among the
current members, about 50% of employ¥÷€ ees have masterchr(34)s ♦→↔↑degrees, and more than
10% have doctoral degree♦s. A platform, a post-doctoral practice anεΩ" d innovation
base, for sustainably§₽ meeting the needs of high-end talents-a postd→>♥✘octoral
practice innov∏₽←ation base has been esta ±™blished. On the other hand,¶ '¶ Yilifang
adheres to the idea of quality as •≤™¶the basis and regulations a €★s the
norm, and has establish♣ed a comprehensive system in terms of q≥≈→Ωuality and
safety, fire safety £∑±and environmental protection. In terms of techn≤♠✘¥ological
innovation, Yilifang has obtainφΩed national, provincial, and muni♠•✘§cipal department’
recognition→Ω ✔ and awards at various levels£β∑ through independent research and
d₹∏¶∑evelopment. In 2017, as the only representδδative of the Shenzhen In vitro
D↓§±iagnostic Reagent Ente<∏rprise Group, it was promotedβ>δγ to the National Innovation
and Entrepre>↑neurship Competition.
Date:2020-03-26
Date:2020-03-30
Date:2020-03-17
Date:2020-03-11
Date:2020-03-03